{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T10:03:49Z","timestamp":1771236229675,"version":"3.50.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,10,10]],"date-time":"2012-10-10T00:00:00Z","timestamp":1349827200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s11033-012-1979-z","type":"journal-article","created":{"date-parts":[[2012,10,9]],"date-time":"2012-10-09T12:12:47Z","timestamp":1349784767000},"page":"10837-10842","source":"Crossref","is-referenced-by-count":20,"title":["IL-1RN VNTR polymorphism and genetic susceptibility to cervical cancer in Portugal"],"prefix":"10.1007","volume":"39","author":[{"given":"Hugo","family":"Sousa","sequence":"first","affiliation":[]},{"given":"Alexandra M.","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Catarino","sequence":"additional","affiliation":[]},{"given":"Daniela","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Moutinho","sequence":"additional","affiliation":[]},{"given":"Paulo","family":"Canedo","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Carlos","family":"Machado","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Medeiros","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,10,10]]},"reference":[{"key":"1979_CR1","unstructured":"Ferlay J et al (2008) GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBAse No. 10 2008"},{"issue":"2","key":"1979_CR2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bpobgyn.2005.10.007","volume":"20","author":"R Sankaranarayanan","year":"2006","unstructured":"Sankaranarayanan R, Ferlay J (2006) Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 20(2):207\u2013225","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"1979_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0042-6822(91)90816-T","volume":"184","author":"H zur Hausen","year":"1991","unstructured":"zur Hausen H (1991) Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184(1):9\u201313","journal-title":"Virology"},{"key":"1979_CR4","first-page":"170","volume":"30","author":"H zur Hausen","year":"1984","unstructured":"zur Hausen H, Gissmann L, Schlehofer JR (1984) Viruses in the etiology of human genital cancer. Prog Med Virol 30:170\u2013186","journal-title":"Prog Med Virol"},{"issue":"6","key":"1979_CR5","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/jnci\/91.6.506","volume":"91","author":"EL Franco","year":"1999","unstructured":"Franco EL, Rohan TE, Villa LL (1999) Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst 91(6):506\u2013511","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"1979_CR6","first-page":"415","volume":"2","author":"FX Bosch","year":"1993","unstructured":"Bosch FX et al (1993) Human papillomavirus and cervical intraepithelial neoplasia grade III\/carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol Biomark Prev 2(5):415\u2013422","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"5","key":"1979_CR7","first-page":"423","volume":"2","author":"N Munoz","year":"1993","unstructured":"Munoz N et al (1993) Risk factors for cervical intraepithelial neoplasia grade III\/carcinoma in situ in Spain and Colombia. Cancer Epidemiol Biomark Prev 2(5):423\u2013431","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"4","key":"1979_CR8","first-page":"301","volume":"115","author":"N Munoz","year":"1993","unstructured":"Munoz N et al (1993) Human papilloma virus in the etiology of cervicouterine cancer. Bol Oficina Sanit Panam 115(4):301\u2013309","journal-title":"Bol Oficina Sanit Panam"},{"issue":"2","key":"1979_CR9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0168-1702(02)00188-0","volume":"89","author":"X Castellsague","year":"2002","unstructured":"Castellsague X, Bosch FX, Munoz N (2002) Environmental co-factors in HPV carcinogenesis. Virus Res 89(2):191\u2013199","journal-title":"Virus Res"},{"issue":"Suppl 1","key":"1979_CR10","first-page":"S1","volume":"24","author":"H Trottier","year":"2006","unstructured":"Trottier H, Franco EL (2006) The epidemiology of genital human papillomavirus infection. Vaccine 24(Suppl 1):S1\u2013S15","journal-title":"Vaccine"},{"issue":"3","key":"1979_CR11","first-page":"209","volume":"130","author":"H zur Hausen","year":"2009","unstructured":"zur Hausen H (2009) Human papillomavirus & cervical cancer. Indian J Med Res 130(3):209","journal-title":"Indian J Med Res"},{"issue":"4","key":"1979_CR12","first-page":"664","volume":"75","author":"MG Cavallo","year":"1992","unstructured":"Cavallo MG et al (1992) Viral infection induces cytokine release by beta islet cells. Immunology 75(4):664\u2013668","journal-title":"Immunology"},{"issue":"1\u201312","key":"1979_CR13","first-page":"65","volume":"86","author":"R Cavallo","year":"1994","unstructured":"Cavallo R, Cavallo F, Cavallo G (1994) The role of cytokines in viral infections. G Batteriol Virol Immunol 86(1\u201312):65\u201378","journal-title":"G Batteriol Virol Immunol"},{"issue":"8","key":"1979_CR14","first-page":"733","volume":"114","author":"M Hurme","year":"1998","unstructured":"Hurme M (1998) Is susceptibility to infections in the genes? Duodecim 114(8):733\u2013734","journal-title":"Duodecim"},{"issue":"22","key":"1979_CR15","doi-asserted-by":"crossref","first-page":"14147","DOI":"10.1016\/S0021-9258(18)98655-2","volume":"266","author":"EV Granowitz","year":"1991","unstructured":"Granowitz EV et al (1991) Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. J Biol Chem 266(22):14147\u201314150","journal-title":"J Biol Chem"},{"key":"1979_CR16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev.immunol.16.1.27","volume":"16","author":"WP Arend","year":"1998","unstructured":"Arend WP et al (1998) Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 16:27\u201355","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"1979_CR17","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2598::AID-IMMU2598>3.0.CO;2-K","volume":"28","author":"M Hurme","year":"1998","unstructured":"Hurme M, Santtila S (1998) IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 28(8):2598\u20132602","journal-title":"Eur J Immunol"},{"issue":"2","key":"1979_CR18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1086\/338261","volume":"34","author":"SS Witkin","year":"2002","unstructured":"Witkin SS, Gerber S, Ledger WJ (2002) Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 34(2):204\u2013209","journal-title":"Clin Infect Dis"},{"issue":"9","key":"1979_CR19","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood.V79.9.2196.2196","volume":"79","author":"E Fischer","year":"1992","unstructured":"Fischer E et al (1992) Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 79(9):2196\u20132200","journal-title":"Blood"},{"issue":"6","key":"1979_CR20","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095","volume":"87","author":"CA Dinarello","year":"1996","unstructured":"Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87(6):2095\u20132147","journal-title":"Blood"},{"issue":"8","key":"1979_CR21","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1182\/blood.V77.8.1627.1627","volume":"77","author":"CA Dinarello","year":"1991","unstructured":"Dinarello CA (1991) Interleukin-1 and interleukin-1 antagonism. Blood 77(8):1627\u20131652","journal-title":"Blood"},{"issue":"4","key":"1979_CR22","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1084\/jem.173.4.931","volume":"173","author":"KW McIntyre","year":"1991","unstructured":"McIntyre KW et al (1991) Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. J Exp Med 173(4):931\u2013939","journal-title":"J Exp Med"},{"issue":"1","key":"1979_CR23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/tpj.2008.16","volume":"9","author":"F Graziano","year":"2009","unstructured":"Graziano F et al (2009) Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer. Pharmacogenomics J 9(1):78\u201384","journal-title":"Pharmacogenomics J"},{"issue":"4","key":"1979_CR24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/sj.bjc.6602729","volume":"93","author":"F Lindmark","year":"2005","unstructured":"Lindmark F et al (2005) Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk. Br J Cancer 93(4):493\u2013497","journal-title":"Br J Cancer"},{"issue":"4","key":"1979_CR25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF00217368","volume":"91","author":"JK Tarlow","year":"1993","unstructured":"Tarlow JK et al (1993) Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 91(4):403\u2013404","journal-title":"Hum Genet"},{"issue":"6776","key":"1979_CR26","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/35006081","volume":"404","author":"EM El-Omar","year":"2000","unstructured":"El-Omar EM et al (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404(6776):398\u2013402","journal-title":"Nature"},{"issue":"6842","key":"1979_CR27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/35083631","volume":"412","author":"EM El-Omar","year":"2001","unstructured":"El-Omar EM et al (2001) The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 412(6842):99","journal-title":"Nature"},{"issue":"6A","key":"1979_CR28","first-page":"3421","volume":"22","author":"J Sehouli","year":"2002","unstructured":"Sehouli J et al (2002) Polymorphism of IL-1 receptor antagonist gene: role in cancer. Anticancer Res 22(6A):3421\u20133424","journal-title":"Anticancer Res"},{"issue":"1","key":"1979_CR29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1744-313X.2010.00975.x","volume":"38","author":"DP Xu","year":"2011","unstructured":"Xu DP et al (2011) VNTR polymorphism of human IL1RN in Chinese Han and She ethnic populations. Int J Immunogenet 38(1):13\u201316","journal-title":"Int J Immunogenet"},{"issue":"1","key":"1979_CR30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cancergencyto.2007.09.011","volume":"180","author":"Y Maruta","year":"2008","unstructured":"Maruta Y et al (2008) Determination of ancestral allele for possible human cancer-associated polymorphisms. Cancer Genet Cytogenet 180(1):24\u201329","journal-title":"Cancer Genet Cytogenet"},{"issue":"5","key":"1979_CR31","first-page":"654","volume":"28","author":"J Xue","year":"2010","unstructured":"Xue J et al (2010) No association of interleukin-1 receptor antagonist VNTR polymorphism and rheumatoid arthritis susceptibility: a meta analysis. Clin Exp Rheumatol 28(5):654\u2013660","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"1979_CR32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/aje\/kwq370","volume":"173","author":"C Persson","year":"2011","unstructured":"Persson C et al (2011) Polymorphisms in inflammatory response genes and their association with gastric cancer: a HuGE systematic review and meta-analyses. Am J Epidemiol 173(3):259\u2013270","journal-title":"Am J Epidemiol"},{"issue":"3","key":"1979_CR33","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1158\/1055-9965.EPI-09-0917","volume":"19","author":"B Peleteiro","year":"2010","unstructured":"Peleteiro B et al (2010) Association between cytokine gene polymorphisms and gastric precancerous lesions: systematic review and meta-analysis. Cancer Epidemiol Biomark Prev 19(3):762\u2013776","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"4","key":"1979_CR34","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/gast.2001.28000","volume":"121","author":"JC Machado","year":"2001","unstructured":"Machado JC et al (2001) Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 121(4):823\u2013829","journal-title":"Gastroenterology"},{"issue":"2","key":"1979_CR35","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0016-5085(03)00899-0","volume":"125","author":"JC Machado","year":"2003","unstructured":"Machado JC et al (2003) A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 125(2):364\u2013371","journal-title":"Gastroenterology"},{"issue":"22","key":"1979_CR36","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/jnci\/94.22.1680","volume":"94","author":"C Figueiredo","year":"2002","unstructured":"Figueiredo C et al (2002) Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 94(22):1680\u20131687","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"1979_CR37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4251\/wjgo.v2.i6.265","volume":"2","author":"F Perri","year":"2010","unstructured":"Perri F et al (2010) Role of interleukin polymorphisms in gastric cancer: \u201cpros and cons\u201d. World J Gastrointest Oncol 2(6):265\u2013271","journal-title":"World J Gastrointest Oncol"},{"issue":"10","key":"1979_CR38","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/j.1440-1746.2010.06428.x","volume":"25","author":"H Xue","year":"2010","unstructured":"Xue H et al (2010) Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a meta-analysis. J Gastroenterol Hepatol 25(10):1604\u20131617","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"1979_CR39","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s10620-010-1557-y","volume":"56","author":"BS He","year":"2011","unstructured":"He BS et al (2011) Polymorphisms in interleukin-1B (IL-1B) and interleukin 1 receptor antagonist (IL-1RN) genes associate with gastric cancer risk in the Chinese population. Dig Dis Sci 56(7):2017\u20132023","journal-title":"Dig Dis Sci"},{"issue":"3","key":"1979_CR40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.humimm.2008.01.012","volume":"69","author":"R Upadhyay","year":"2008","unstructured":"Upadhyay R et al (2008) Potential influence of interleukin-1 haplotype IL-1 beta-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: a case-control study. Hum Immunol 69(3):179\u2013186","journal-title":"Hum Immunol"},{"issue":"2","key":"1979_CR41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cancergencyto.2008.05.004","volume":"186","author":"M Vishnoi","year":"2008","unstructured":"Vishnoi M et al (2008) IL-1 gene polymorphisms and genetic susceptibility of gallbladder cancer in a north Indian population. Cancer Genet Cytogenet 186(2):63\u201368","journal-title":"Cancer Genet Cytogenet"},{"issue":"4","key":"1979_CR42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/13547500902818246","volume":"14","author":"DK Ahirwar","year":"2009","unstructured":"Ahirwar DK et al (2009) Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy. Biomarkers 14(4):213\u2013218","journal-title":"Biomarkers"},{"issue":"5","key":"1979_CR43","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.urology.2005.11.032","volume":"67","author":"HK Bid","year":"2006","unstructured":"Bid HK, Manchanda PK, Mittal RD (2006) Association of interleukin-1Ra gene polymorphism in patients with bladder cancer: case control study from North India. Urology 67(5):1099\u20131104","journal-title":"Urology"},{"issue":"2","key":"1979_CR44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10549-005-9079-6","volume":"96","author":"KM Lee","year":"2006","unstructured":"Lee KM et al (2006) Genetic polymorphisms of interleukin-1 beta (IL-1B) and IL-1 receptor antagonist (IL-1RN) and breast cancer risk in Korean women. Breast Cancer Res Treat 96(2):197\u2013202","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"1979_CR45","first-page":"915","volume":"14","author":"HT Viet","year":"2005","unstructured":"Viet HT et al (2005) Interleukin-1 receptor antagonist gene polymorphism in human colorectal cancer. Oncol Rep 14(4):915\u2013918","journal-title":"Oncol Rep"},{"issue":"2","key":"1979_CR46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/FPC.0b013e32831a9ad1","volume":"19","author":"G Lurje","year":"2009","unstructured":"Lurje G et al (2009) Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer. Pharmacogenet Genomics 19(2):95\u2013102","journal-title":"Pharmacogenet Genomics"},{"issue":"3","key":"1979_CR47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.lungcan.2005.07.003","volume":"50","author":"H Lind","year":"2005","unstructured":"Lind H et al (2005) Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: a possible interaction with polymorphisms in the interleukin 1 beta gene. Lung Cancer 50(3):285\u2013290","journal-title":"Lung Cancer"},{"issue":"4","key":"1979_CR48","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/carcin\/bgr006","volume":"32","author":"WY Lim","year":"2011","unstructured":"Lim WY et al (2011) Polymorphisms in inflammatory pathway genes, host factors and lung cancer risk in Chinese female never-smokers. Carcinogenesis 32(4):522\u2013529","journal-title":"Carcinogenesis"},{"issue":"2","key":"1979_CR49","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.canlet.2005.05.015","volume":"236","author":"Z Hu","year":"2006","unstructured":"Hu Z et al (2006) Allele 2 of the interleukin-1 receptor antagonist gene (IL1RN*2) is associated with a decreased risk of primary lung cancer. Cancer Lett 236(2):269\u2013275","journal-title":"Cancer Lett"},{"issue":"2","key":"1979_CR50","first-page":"15","volume":"15","author":"A Settin","year":"2008","unstructured":"Settin A, Ali N, Salem FK (2008) Cytokine gene polymorphisms in Egyptian cases with brain tumors. Egypt J Immunol 15(2):15\u201323","journal-title":"Egypt J Immunol"},{"issue":"2","key":"1979_CR51","first-page":"101","volume":"21","author":"NK Badr El-Din","year":"2009","unstructured":"Badr El-Din NK et al (2009) Cytokine gene polymorphisms in Egyptian cases with brain tumors. J Egypt Natl Cancer Inst 21(2):101\u2013106","journal-title":"J Egypt Natl Cancer Inst"},{"issue":"3","key":"1979_CR52","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/mc.20706","volume":"50","author":"ZH Yang","year":"2011","unstructured":"Yang ZH et al (2011) Association of IL-1 polymorphisms and IL-1 serum levels with susceptibility to nasopharyngeal carcinoma. Mol Carcinog 50(3):208\u2013214","journal-title":"Mol Carcinog"},{"issue":"6","key":"1979_CR53","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00404-007-0504-4","volume":"277","author":"DM Tamandani","year":"2008","unstructured":"Tamandani DM et al (2008) Impact of polymorphism in IL-1RA gene on the risk of cervical cancer. Arch Gynecol Obstet 277(6):527\u2013533","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"1979_CR54","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1471-0528.2007.01655.x","volume":"115","author":"H Singh","year":"2008","unstructured":"Singh H et al (2008) Genetic variants of interleukin-1RN and interleukin-1beta genes and risk of cervical cancer. BJOG 115(5):633\u2013638","journal-title":"BJOG"},{"issue":"2A","key":"1979_CR55","first-page":"1099","volume":"23","author":"A Mustea","year":"2003","unstructured":"Mustea A et al (2003) Interleukin 1 receptor antagonist (IL-1RA) polymorphism in women with cervical cancer. Anticancer Res 23(2A):1099\u20131102","journal-title":"Anticancer Res"},{"issue":"5","key":"1979_CR56","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00432-009-0710-5","volume":"136","author":"N Qian","year":"2010","unstructured":"Qian N et al (2010) Circulating IL-1beta levels, polymorphisms of IL-1B, and risk of cervical cancer in Chinese women. J Cancer Res Clin Oncol 136(5):709\u2013716","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"1979_CR57","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/aje\/kwn359","volume":"169","author":"S Rodriguez","year":"2009","unstructured":"Rodriguez S, Gaunt TR, Day IN (2009) Hardy\u2013Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol 169(4):505\u2013514","journal-title":"Am J Epidemiol"},{"issue":"3","key":"1979_CR58","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1590\/S1415-47572009000300028","volume":"32","author":"MS Lauretto","year":"2009","unstructured":"Lauretto MS et al (2009) A straightforward multiallelic significance test for the Hardy\u2013Weinberg equilibrium law. Genet Mol Biol 32(3):619\u2013625","journal-title":"Genet Mol Biol"},{"issue":"1","key":"1979_CR59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cancergencyto.2004.11.017","volume":"160","author":"R Catarino","year":"2005","unstructured":"Catarino R et al (2005) Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism. Cancer Genet Cytogenet 160(1):49\u201354","journal-title":"Cancer Genet Cytogenet"},{"issue":"12","key":"1979_CR60","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00432-002-0391-9","volume":"128","author":"S Costa","year":"2002","unstructured":"Costa S et al (2002) A slow acetylator genotype associated with an increased risk of advanced cervical cancer. J Cancer Res Clin Oncol 128(12):678\u2013682","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"1979_CR61","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.bbrc.2005.06.137","volume":"334","author":"I Duarte","year":"2005","unstructured":"Duarte I et al (2005) G-308A TNF-alpha polymorphism is associated with an increased risk of invasive cervical cancer. Biochem Biophys Res Commun 334(2):588\u2013592","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1979_CR62","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cancergencyto.2003.08.020","volume":"150","author":"R Craveiro","year":"2004","unstructured":"Craveiro R et al (2004) TP73 alterations in cervical carcinoma. Cancer Genet Cytogenet 150(2):116\u2013121","journal-title":"Cancer Genet Cytogenet"},{"issue":"14","key":"1979_CR63","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0959-8049(02)00241-1","volume":"38","author":"PJ Farrell","year":"2002","unstructured":"Farrell PJ (2002) Tumour viruses\u2014could they be an Achilles\u2019 heel of cancer? Eur J Cancer 38(14):1815\u20131816","journal-title":"Eur J Cancer"},{"issue":"3","key":"1979_CR64","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/oxfordjournals.bmb.a072910","volume":"50","author":"KH Vousden","year":"1994","unstructured":"Vousden KH, Farrell PJ (1994) Viruses and human cancer. Br Med Bull 50(3):560\u2013581","journal-title":"Br Med Bull"},{"issue":"4","key":"1979_CR65","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000106492","volume":"64","author":"A Coelho","year":"2007","unstructured":"Coelho A et al (2007) The influence of chemokine receptor CCR2 genotypes in the route to cervical carcinogenesis. Gynecol Obstet Invest 64(4):208\u2013212","journal-title":"Gynecol Obstet Invest"},{"issue":"15","key":"1979_CR66","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1096\/fasebj.8.15.8001745","volume":"8","author":"CA Dinarello","year":"1994","unstructured":"Dinarello CA (1994) The interleukin-1 family: 10\u00a0years of discovery. FASEB J 8(15):1314\u20131325","journal-title":"FASEB J"},{"issue":"2","key":"1979_CR67","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1056\/NEJM199301143280207","volume":"328","author":"CA Dinarello","year":"1993","unstructured":"Dinarello CA, Wolff SM (1993) The role of interleukin-1 in disease. N Engl J Med 328(2):106\u2013113","journal-title":"N Engl J Med"},{"issue":"1","key":"1979_CR68","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.urology.2008.08.464","volume":"73","author":"S Kapoor","year":"2009","unstructured":"Kapoor S (2009) Role of polymorphisms of interleukin-1 receptor antagonist gene in systemic oncogenesis: significant etiopathologic connections besides in benign prostatic hyperplasia. Urology 73(1):215","journal-title":"Urology"},{"issue":"12","key":"1979_CR69","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.4049\/jimmunol.156.12.4884","volume":"156","author":"CJ Roberge","year":"1996","unstructured":"Roberge CJ et al (1996) The IL-1 and IL-1 receptor antagonist (IL-1Ra) response of human neutrophils to EBV stimulation. Preponderance of IL-Ra detection. J Immunol 156(12):4884\u20134891","journal-title":"J Immunol"},{"issue":"3","key":"1979_CR70","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1365-3083.1998.00406.x","volume":"48","author":"M Hurme","year":"1998","unstructured":"Hurme M, Helminen M (1998) Polymorphism of the IL-1 gene complex in Epstein-Barr virus seronegative and seropositive adult blood donors. Scand J Immunol 48(3):219\u2013222","journal-title":"Scand J Immunol"},{"issue":"5","key":"1979_CR71","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/ijc.20935","volume":"115","author":"GA Rocha","year":"2005","unstructured":"Rocha GA et al (2005) IL1RN polymorphic gene and cagA-positive status independently increase the risk of noncardia gastric carcinoma. Int J Cancer 115(5):678\u2013683","journal-title":"Int J Cancer"},{"issue":"1","key":"1979_CR72","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/j.gastro.2004.03.069","volume":"127","author":"DM Queiroz","year":"2004","unstructured":"Queiroz DM et al (2004) IL1B and IL1RN polymorphic genes and Helicobacter pylori cagA strains decrease the risk of reflux esophagitis. Gastroenterology 127(1):73\u201379","journal-title":"Gastroenterology"},{"issue":"1","key":"1979_CR73","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/jhep.2003.50017","volume":"37","author":"Y Wang","year":"2003","unstructured":"Wang Y et al (2003) Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 37(1):65\u201371","journal-title":"Hepatology"},{"issue":"11","key":"1979_CR74","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/gut.2007.143578","volume":"57","author":"P Canedo","year":"2008","unstructured":"Canedo P et al (2008) The interferon gamma receptor 1 (IFNGR1) -56C\/T gene polymorphism is associated with increased risk of early gastric carcinoma. Gut 57(11):1504\u20131508","journal-title":"Gut"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-012-1979-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-012-1979-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-012-1979-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T04:44:54Z","timestamp":1687754694000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-012-1979-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,10]]},"references-count":74,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1979"],"URL":"https:\/\/doi.org\/10.1007\/s11033-012-1979-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,10]]}}}